John Hennessy, Associate Principal at Payer Sciences, shared a post on LinkedIn:
“I have no doubt that oncology pharmacists add great value to the care of persons impacted by cancer. It’s unfortunate that we feel that the only way to recognize value is through a billable service. That’s ‘the more we do, the more we make’; and that passes on costs to consumers who are already challenged financially. That’s broken.”
Title: Assessment of Standards of Care for Oral Chemotherapy by Pharmacists in Clinical Settings
Authors: Sara Nezirevic, Benyam Muluneh, Jennifer Elston Lafata, Casey Eisinger, Solomea Asfaw, Alison Butts, Karen B. Farris
You can read the full article in Journal of the Advanced Practitioner in Oncology (JADPRO).
